Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL
NCT02836158
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Primary Central Nervous System Lymphoma
Interventions
DRUG:
R-IDARAM plus intrathecal chemotherapy
Sponsor
Navy General Hospital, Beijing